Roivant Sciences’ experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm’s… Reuters Health Information
Category: News
ADDING MULTIMEDIA Eye Physicians of Libertyville Acquires Northern Illinois Eye Clinic
LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Effective March 28, 2024, Eye Physicians of Libertyville doctors will assume care for Northern Illinois Eye Clinic patients. “Dr. Velotta is a well-respected ophthalmologist in our community, and I wish her the best…
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
Optometrist Sues After Firing On Return From Maternity Leave
Lawsuit claimed Seattle-area eye surgery practice engaged in gender discrimination and workplace retaliation. Medscape Medical News
Overlord or Underachiever: AI Poised to Disrupt Eye Care
Recent studies report artificial intelligence can match wits with ophthalmologists in answering patients’ questions and may soon assist clinicians in managing patient flow. Medscape Medical News
Global Sports Optics Analysis 2023: A $2.73 Billion Market by 2029 Featuring Key vendors – Nikon, Swarovski, Beretta, Vortex, Leica Camera, Carlyle group, ATN, and Trijicon Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Sports Optics Market: Analysis By Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029” report has been added to ResearchAndMarkets.com’s offering. The global sports optics market value st…
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the pricing o…
MyEyeDr. Partners with Prevent Blindness to Promote Eye Health and Safety During April 8 Solar Eclipse, Gives Away Solar Glasses at 400+ Locations
VIENNA, Va.–(BUSINESS WIRE)–Ahead of the total solar eclipse on Monday, April 8, MyEyeDr., a leading provider of eye health services with over 800 locations across the U.S., is educating consumers about the importance of eye health and the need for p…
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
PLEASANTON, Calif.–(BUSINESS WIRE)– #Ophthalmology–RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA Clinical Trial in Translational Vision Science and Technology (TVST), a prestigious journal by the A…
Horus Pharma Renews Its Partnership With Plastic Bank
NICE, France–(BUSINESS WIRE)–Horus Pharma, an independent French laboratory specialised in ophthalmology known for its expertise in developing preservative-free products designed to facilitate eye and eyelid health, has extended its successful collab…
GenSight Biologics Reports Full Year 2023 Consolidated Financial Results
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
EMA Approves Ocular Formulation of Bevacizumab
Europe has approved the use of monoclonal antibody bevacizumab for the treatment of neovascular age-related macular degeneration. Medscape Medical News
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, Inc. (Nasdaq: LENZ) (LENZ or the Company), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people wit…
Vision Impairment Tied to Isolation, Depression
Impaired vision also was linked to symptoms of anxiety in a study of older adults in the United States. Medscape Medical News
Patients With Sjögren Syndrome Fall Into Distinct Subgroups
Those with high systemic disease activity but low symptom burden fared worse over time. Medscape Medical News
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections Four Years After One-Time Administration
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics confirme l’efficacité et la sécurité durables des injections bilatérales de LUMEVOQ® quatre ans après une administration unique
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les …
Tilak Healthcare Strengthens Its Leadership Team
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a leading company in digital health for the monitoring of chronic eye diseases, announces the appointment of three experts to support the leadership team, currently composed of Edouard Gasser (CEO & co-foun…
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more t…
Long-Release Implant Available for Diabetic Macular Oedema
The implant requires less frequent replacement than the dexamethasone alternative. Medscape News UK